about
Preclinical evaluation of NF-κB-triggered dendritic cells expressing the viral oncogenic driver of Merkel cell carcinoma for therapeutic vaccination.Redirecting T cells to Ewing's sarcoma family of tumors by a chimeric NKG2D receptor expressed by lentiviral transduction or mRNA transfection.Concurrent interaction of DCs with CD4(+) and CD8(+) T cells improves secondary CTL expansion: It takes three to tango.Just one position-independent lysine residue can direct MelanA into proteasomal degradation following N-terminal fusion of ubiquitin.Human adenovirus-specific γ/δ and CD8+ T cells generated by T-cell receptor transfection to treat adenovirus infection after allogeneic stem cell transplantation.Transfer of mRNA Encoding Invariant NKT Cell Receptors Imparts Glycolipid Specific Responses to T Cells and γδT CellsNonviral RNA transfection to transiently modify T cells with chimeric antigen receptors for adoptive therapy.Transcriptional Targeting of Mature Dendritic Cells with Adenoviral Vectors via a Modular Promoter System for Antigen Expression and Functional Manipulation.Stability and activity of MCSP-specific chimeric antigen receptors (CARs) depend on the scFv antigen-binding domain and the protein backbone.Generation of CD8(+) T cells expressing two additional T-cell receptors (TETARs) for personalised melanoma therapy.A new method to monitor antigen-specific CD8+ T cells, avoiding additional target cells and the restriction to human leukocyte antigen haplotype.A GMP-compliant protocol to expand and transfect cancer patient T cells with mRNA encoding a tumor-specific chimeric antigen receptor.Norm- and hypo-fractionated radiotherapy is capable of activating human dendritic cells.T-cell receptor transfer for boosting HIV-1-specific T-cell immunity in HIV-1-infected patients.Selection of adenovirus-specific and Epstein-Barr virus-specific T cells with major histocompatibility class I streptamers under Good Manufacturing Practice (GMP)-compliant conditions.RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma.Immune checkpoint blockade can synergize with radiation therapy, even in tumors resistant to checkpoint monotherapyElectroporated Antigen-Encoding mRNA Is Not a Danger Signal to Human Mature Monocyte-Derived Dendritic Cells.Resveratrol induces extensive apoptosis by depolarizing mitochondrial membranes and activating caspase-9 in acute lymphoblastic leukemia cells.Autocrine TNF is critical for the survival of human dendritic cells by regulating BAK, BCL-2, and FLIPL.Generation of HIV-1-specific T cells by electroporation of T-cell receptor RNA.Transfer of mRNA encoding recombinant immunoreceptors reprograms CD4+ and CD8+ T cells for use in the adoptive immunotherapy of cancer.Vaccination with antigen-transfected, NKT cell ligand-loaded, human cells elicits robust in situ immune responses by dendritic cells.Leukoreduction system chambers are an efficient, valid, and economic source of functional monocyte-derived dendritic cells and lymphocytes.A fast and robust method to clone and functionally validate T-cell receptors.HIV-1 mRNA electroporation of PBMC: a simple and efficient method to monitor T-cell responses against autologous HIV-1 in HIV-1-infected patients.BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells: Consequences for Adoptive T-Cell Therapy.Electroporation of mRNA as Universal Technology Platform to Transfect a Variety of Primary Cells with Antigens and Functional Proteins.CD8(+) T-cell priming and boosting: more antigen-presenting DC, or more antigen per DC?Sarcoidosis Under Dendritic Cell Vaccination Immunotherapy in Long-term Responding Patients with Metastatic Melanoma.Effective clinical-scale production of dendritic cell vaccines by monocyte elutriation directly in medium, subsequent culture in bags and final antigen loading using peptides or RNA transfection.Generation of an optimized polyvalent monocyte-derived dendritic cell vaccine by transfecting defined RNAs after rather than before maturation.Triggering of NF-κB in cytokine-matured human DCs generates superior DCs for T-cell priming in cancer immunotherapy.Combining a chimeric antigen receptor and a conventional T-cell receptor to generate T cells expressing two additional receptors (TETARs) for a multi-hit immunotherapy of melanoma.Regulation of CD95 expression and CD95-mediated cell death by interferon-gamma in acute lymphoblastic leukemia with chromosomal translocation t(4;11).Mild hyperthermia enhances human monocyte-derived dendritic cell functions and offers potential for applications in vaccination strategies.An improved method for RNA isolation and removal of melanin contamination from melanoma tissue: implications for tumor antigen detection and amplificationStrategies for immune intervention; from bench to bedside: Symposium 2006 of the Collaborative Research Center "Strategies of cellular immune intervention" July 17th-18th, Erlangen, GermanyDendritic cell vaccination and other strategies to tip the balance of the immune system : DC2007 5th International Meeting, July 16-18, Bamberg, GermanyIntroduction of functional chimeric E/L-selectin by RNA electroporation to target dendritic cells from blood to lymph nodes
P50
Q33887689-ED742CE6-58AA-483F-994C-B399CFC752F0Q34166288-6ACD4325-E630-4C40-9455-1397080CD1DDQ34438014-130C39CB-4329-47BC-B287-89090EA81AEEQ34581001-176D4FF6-032A-4629-B73A-00DD9599F5B4Q35308252-185C710F-8306-402C-A681-7ABB0CB43EFEQ35677421-28469701-FD71-4E0B-8EC7-58E06B55B4D1Q38072377-B06E3322-D8B2-438F-9977-139A66D6CDAFQ38756454-595F3E08-1C9F-449F-A1A9-EC11B930D754Q38823747-74BDC935-E899-4211-A151-CA48EDB7F493Q38852674-F5672229-44EB-472E-939B-572A9A06E8A2Q38897933-40465029-ADB3-4A1E-BFC6-6909057DCF0AQ38983814-D498884F-432E-40AD-AD39-94E243451D6BQ39025449-42D14E80-9D61-40CB-ACE6-8E378B11451FQ40646993-882F9CFB-F32A-4076-B278-8F4ABE7F9B65Q41340903-9C4A9384-B270-4487-8703-D326B9A42572Q41450925-0B4E3336-6A0B-40BE-A596-71A36A49501CQ41922909-96CF27EE-8B79-4E39-B0EC-98D1156B9389Q43097170-917E6CAD-BADE-433D-9B0E-A719144A71C2Q43640339-A6805D09-BCEE-42F7-B850-570DC1D9A5C6Q43995176-4D6CB068-429D-4462-9F55-B27531D4B3C7Q44829656-FAA01673-F77E-447D-981F-EC816A33B95DQ45882718-E8A1D4CD-441B-4C02-B06A-C64598F9D4E1Q46146104-B5F42DCD-7829-4A18-9426-83FB2378588EQ46174588-E9DA903C-335E-4779-9F6E-7C4223A1B1D4Q47848134-7ED693ED-0B61-42EF-BF96-AC53588C4D50Q47892252-59467873-CF2F-4A80-A196-48C16879F252Q48218708-B0ECB1ED-BC1A-452D-AEF6-31A8465CA641Q50035982-113AFDF0-5A83-4B3B-BEB2-9C0A8D941D89Q50471175-FC668E0E-0ABB-4329-B923-1BA0ED8CA1A4Q50618567-F2B97EF7-AC03-4471-9751-DFBC0CB8A1ACQ50671523-44DF39C8-34E5-46BA-9081-68AFE16A9C8BQ50777089-FCE7846A-077C-44DD-AC2D-9B8FBF063AD9Q50788340-8F186AD3-A93C-46DE-BFB2-FA78E3B1CEFAQ52859139-F3860E66-9719-4425-8F3F-F867557EB1EAQ54076442-0293B4CB-2D0D-4815-934D-F0A3F69C0732Q64983621-6BB73FB2-CDE3-4714-9F45-126E14BCE1AEQ79741842-B037554B-9FFE-4460-A261-1E745A73963CQ80059594-E682592B-49F5-46E4-9A48-ADF797BF1831Q80597442-6A979832-DB46-44BB-BBBE-E48787F3063AQ80985352-02FB7A55-2BED-445E-BE1B-455C46E54FBD
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jan Dörrie
@ast
Jan Dörrie
@en
Jan Dörrie
@es
Jan Dörrie
@nl
Jan Dörrie
@sl
type
label
Jan Dörrie
@ast
Jan Dörrie
@en
Jan Dörrie
@es
Jan Dörrie
@nl
Jan Dörrie
@sl
prefLabel
Jan Dörrie
@ast
Jan Dörrie
@en
Jan Dörrie
@es
Jan Dörrie
@nl
Jan Dörrie
@sl
P1053
H-3678-2011
P106
P1153
17341898900
P21
P31
P3829
P496
0000-0002-3478-0741